TipRanks on MSN

Travere Therapeutics’ Study on Homocystinuria: A Closer Look at the ACAPPELLA Study

Travere Therapeutics, Inc. (($TVTX)) announced an update on their ongoing clinical study. Travere Therapeutics, Inc. is conducting a study titled ...
WDAF-TV

Aeglea BioTherapeutics Announces Interim Results from Ongoing Phase 1/2 Clinical Trial of Pegtarviliase for the Treatment of Classical Homocystinuria and Begins Process to ...

AUSTIN, Texas, April 12, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing human enzyme therapeutics to benefit people with rare ...